Dr Reddy's Laboratories Ltd
DRREDDYDr Reddy's Laboratories Ltd
DRREDDY
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 18.93 | 4.14 | 0.69% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.31 | 5.09 | 0.71% |
Forecast & Ratings
Detailed Forecastfrom 37 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 15,297.40 | 15,863.30 | 14,367.60 | 14,436.20 | 15,829.50 | 18,193.70 | 19,386.90 | 22,099.90 | 25,762.20 | 27,473.80 | ||||||||||
Raw Materials | 3,842.20 | 3,854.20 | 3,819.80 | 4,081.00 | 4,770.20 | 5,530.70 | 6,869.40 | 7,796.10 | 7,586.80 | 19,222.70 | ||||||||||
| Power & Fuel Cost | 339.10 | 315.20 | 330.10 | 329.30 | 329.10 | 314.80 | 320.50 | 390.50 | 477.40 | |||||||||||
| Employee Cost | 2,944.60 | 3,117.40 | 3,106.80 | 3,214.90 | 3,356.20 | 3,380.20 | 3,629.90 | 3,885.80 | 4,646.60 | |||||||||||
| Selling & Administrative Expenses | 3,108.30 | 3,007.00 | 3,287.10 | 2,106.10 | 2,235.30 | 2,184.20 | 2,398.30 | 2,976.10 | 3,132.30 | |||||||||||
| Operating & Other expenses | 1,295.50 | 1,689.20 | 1,180.10 | 2,198.50 | 1,579.20 | 3,636.70 | 1,959.50 | 2,729.00 | 2,477.60 | |||||||||||
EBITDA | 3,767.70 | 3,880.30 | 2,643.70 | 2,506.40 | 3,559.50 | 3,147.10 | 4,209.30 | 4,322.40 | 7,441.50 | 8,251.10 | ||||||||||
| Depreciation/Amortization | 759.90 | 938.90 | 1,026.60 | 1,077.20 | 1,134.80 | 1,163.10 | 1,228.80 | 1,165.20 | 1,250.20 | 1,368.00 | ||||||||||
| PBIT | 3,007.80 | 2,941.40 | 1,617.10 | 1,429.20 | 2,424.70 | 1,984.00 | 2,980.50 | 3,157.20 | 6,191.30 | 6,883.10 | ||||||||||
| Interest & Other Items | 108.20 | 82.60 | 63.40 | 78.80 | 88.90 | 98.30 | 97.00 | 95.80 | 142.80 | 149.60 | ||||||||||
| PBT | 2,899.60 | 2,858.80 | 1,553.70 | 1,350.40 | 2,335.80 | 1,885.70 | 2,883.50 | 3,061.40 | 6,048.50 | 6,733.50 | ||||||||||
| Taxes & Other Items | 563.20 | 728.20 | 261.60 | 403.60 | 385.80 | -140.30 | 931.90 | 878.90 | 1,541.20 | 1,642.30 | ||||||||||
| Net Income | 2,336.40 | 2,130.60 | 1,292.10 | 946.80 | 1,950.00 | 2,026.00 | 1,951.60 | 2,182.50 | 4,507.30 | 5,091.20 | ||||||||||
| EPS | 137.24 | 124.97 | 76.83 | 57.10 | 117.48 | 121.96 | 117.40 | 131.19 | 270.75 | 305.73 | ||||||||||
| DPS | 20.00 | 20.00 | 20.00 | 20.00 | 20.00 | 25.00 | 25.00 | 30.00 | 40.00 | 40.00 | ||||||||||
| Payout ratio | 0.15 | 0.16 | 0.26 | 0.35 | 0.17 | 0.20 | 0.21 | 0.23 | 0.15 | 0.13 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dr Reddy's Laboratories Ltd | 21.38 | 4.14 | 0.69% |
| Sun Pharmaceutical Industries Ltd | 34.71 | 4.96 | 0.94% |
| Cipla Ltd | 34.93 | 4.13 | 0.70% |
| Mankind Pharma Ltd | 59.30 | 9.97 | — |
Price Comparison
Compare DRREDDY with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 2.68%
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Dr Reddy's Laboratories Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
HDFC Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.6683% | Percentage of the fund’s portfolio invested in the stock 1.63% | Change in the portfolio weight of the stock over the last 3 months -0.13% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 19/51 (0) |
Parag Parikh Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.4521% | Percentage of the fund’s portfolio invested in the stock 0.99% | Change in the portfolio weight of the stock over the last 3 months 0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 22/54 (+1) |
HDFC ELSS Tax saver - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.3410% | Percentage of the fund’s portfolio invested in the stock 2.86% | Change in the portfolio weight of the stock over the last 3 months -0.76% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 14/42 (-2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Dr Reddy's Laboratories Ltd
Events
Dividend Trend
No Dividend Cuts
DRREDDY has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.69%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.91 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 11, 2023
Dividend/Share
₹40.00
Ex DateEx Date
Jul 11, 2023
Cash Dividend
Ex DateEx DateJul 11, 2022
Dividend/Share
₹30.00
Ex DateEx Date
Jul 11, 2022
Cash Dividend
Ex DateEx DateJul 9, 2021
Dividend/Share
₹25.00
Ex DateEx Date
Jul 9, 2021
Cash Dividend
Ex DateEx DateJul 13, 2020
Dividend/Share
₹25.00
Ex DateEx Date
Jul 13, 2020
Cash Dividend
Ex DateEx DateJul 15, 2019
Dividend/Share
₹20.00
Ex DateEx Date
Jul 15, 2019
News & Opinions
Diwali 2023: HDFC Securities Enlists Stocks To Buy During Muhurat Trading - News18
3 weeks ago•News18
News Video
Indices Open Marginally Lower, Sensex Down 183 Points, Nifty Around 19,040 | CNBC TV18
1 month ago•CNBC-TV18
Q2 Review: Dr Reddy’s Labs’ Profit Sees Double-Digit Growth
1 month ago•Bloomberg Quint
News Video
Q2 Review: Dr Reddy's Labs' Profit Sees Double-Digit Growth | BQ Prime
1 month ago•BQ Prime
Dr Reddy’s Q2 Results: Net Profit Jumps 33% to Rs 1,482 Crore - News18
1 month ago•News18
Dr Reddy’s Laboratories Q2 Results: Profit Rises, Beats Estimates
1 month ago•Bloomberg Quint
News Video
Indices End On A Weak Note, Nifty Below 19,700, Sensex Down 550 Points | CNBC TV18
1 month ago•CNBC-TV18
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 12.28%, vs industry avg of 8.45%
Increasing Market Share
Over the last 5 years, market share increased from 7.11% to 8.07%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 36.63%, vs industry avg of 9.82%